Literature DB >> 20677905

Radiation-inducible PTEN expression radiosensitises hepatocellular carcinoma cells.

Yong Zhang1, Long-Hua Chen, Li Wang, Hong-Mei Wang, Yao-Wei Zhang, Yu-Sheng Shi.   

Abstract

PURPOSE: To test the radiosensitising effects of a tumour-suppressor gene, phosphatase and tensin homologue deleted from chromosome 10 (PTEN), in hepatocellular carcinoma cells (HCC).
MATERIALS AND METHODS: Radiation-induced wild-type PTEN or mutant PTEN was transfected into the SMMC-7721 human hepatocellular carcinoma cells. The expressions of PTEN and serine/threonine protein kinase (Akt) were detected by Western blot analysis. 3-(4,5)-dimethylthiahiazo-(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) absorbance and clonogenic survival assays were used to determine cell viability, proliferation and radiosensitivity. By performing cell-cycle analysis, terminal deoxynucleotidyltransferase (TdT)-mediated dUTP biotin nick end labelling (TUNEL) assays and gamma-histone H2A (γ-H2AX) formation assays, we were able to explore the mechanism of PTEN enhancement of radiosensitivity.
RESULTS: Restoration of wild-type PTEN induced growth suppression and sensitised the cells to ionising radiation specifically by its lipid phosphatase activity through the PTEN-phosphatidylinositol 3-kinase (PI3K)-Akt signalling pathway. Restoring PTEN function correlated with G2/M arrest, apoptosis and the retardation of repair of radiation-induced double strand breaks (DSB).
CONCLUSIONS: Our study suggests that strategies designed to restore the expression of PTEN may represent promising new therapies for sensitising HCC cells to ionising radiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677905     DOI: 10.3109/09553002.2010.496032

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  3 in total

1.  Radiosensitisation of human glioma cells by inhibition of β1,6-GlcNAc branched N-glycans.

Authors:  Li Shen; Xiao-Xia Dong; Jun-Bo Wu; Li Qiu; Qi-Wen Duan; Zhi-Guo Luo
Journal:  Tumour Biol       Date:  2015-11-03

2.  Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner.

Authors:  Qiaoqiao Li; Yonghong Hu; Mian Xi; Liru He; Lei Zhao; Mengzhong Liu
Journal:  BMC Cancer       Date:  2012-10-22       Impact factor: 4.430

3.  ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.

Authors:  Hailong Sheng; Yan Huang; Yazhi Xiao; Zhenru Zhu; Mengying Shen; Peitao Zhou; Zeqin Guo; Jian Wang; Hui Wang; Wencong Dai; Wanjun Zhang; Jingyuan Sun; Chuanhui Cao
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.